Sanofi's mRNA vaccine for chlamydia has received fast track designation from the FDA. The vaccine aims to prevent the most common sexually transmitted bacterial infection worldwide, offering a promising solution to the public health challenge. Clinical trials are set to begin soon to evaluate its safety and efficacy.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing